{"id":73314,"date":"2025-07-16T10:04:51","date_gmt":"2025-07-16T08:04:51","guid":{"rendered":"https:\/\/fournel-advisory.com\/?post_type=transaction&p=73314"},"modified":"2025-07-16T10:07:00","modified_gmt":"2025-07-16T08:07:00","slug":"conseil-ma-buy-side","status":"publish","type":"transaction","link":"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/","title":{"rendered":"CONSEIL M&A BUY-SIDE"},"content":{"rendered":"

FOURNEL ADVISORY advises ATHENA PHARMACEUTIQUES on the acquisition, alongside SUBSTIPHARM, of a shared controlling interest in VECTANS PHARMA<\/p>\n\n\n\n

Athena develops and manufactures high value-added medicines for both mature and emerging markets. The company offers an integrated platform covering the full value chain\u2014from R&D to commercialization\u2014through its two manufacturing sites in France and India (with a third site planned for 2026) and its R&D centers.<\/p>\n\n\n\n

This joint investment enables Athena Pharmaceutiques to partner with a differentiated technology player, integrate a portfolio of innovative products already marketed in over 75 countries, and strengthen its international footprint in high-value therapeutic segments.<\/p>\n\n\n\n

Vectans is a French pharmaceutical company specialized in muco-adhesive treatments for oral and vaginal conditions. The company markets two innovative best-in-class drugs, distributed across 78 countries, and is developing a pipeline of more than 10 drug candidates formulated using its proprietary Lauriad\u00ae technology.<\/p>","protected":false},"excerpt":{"rendered":"

FOURNEL ADVISORY accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition, aux c\u00f4t\u00e9s de SUBSTIPHARM, d\u2019une participation conjointe majoritaire au capital de VECTANS PHARMA. Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]<\/p>","protected":false},"author":1,"featured_media":73315,"template":"","type_transaction":[93],"class_list":["post-73314","transaction","type-transaction","status-publish","has-post-thumbnail","hentry","type_transaction-acquisition"],"acf":[],"yoast_head":"\nCONSEIL M&A BUY-SIDE - FOURNEL ADVISORY<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CONSEIL M&A BUY-SIDE - FOURNEL ADVISORY\" \/>\n<meta property=\"og:description\" content=\"FOURNEL ADVISORY accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition, aux c\u00f4t\u00e9s de SUBSTIPHARM, d\u2019une participation conjointe majoritaire au capital de VECTANS PHARMA. Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/\" \/>\n<meta property=\"og:site_name\" content=\"FOURNEL ADVISORY\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T08:07:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"730\" \/>\n\t<meta property=\"og:image:height\" content=\"729\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/\",\"url\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/\",\"name\":\"CONSEIL M&A BUY-SIDE - FOURNEL ADVISORY\",\"isPartOf\":{\"@id\":\"https:\/\/fournel-advisory.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png\",\"datePublished\":\"2025-07-16T08:04:51+00:00\",\"dateModified\":\"2025-07-16T08:07:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage\",\"url\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png\",\"contentUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png\",\"width\":730,\"height\":729},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/fournel-advisory.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions\",\"item\":\"https:\/\/fournel-advisory.com\/transactions\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CONSEIL M&A BUY-SIDE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fournel-advisory.com\/#website\",\"url\":\"https:\/\/fournel-advisory.com\/\",\"name\":\"FOURNEL ADVISORY\",\"description\":\"Une soci\u00e9t\u00e9 de conseil sp\u00e9cialis\u00e9e en fusions-acquisitions, lev\u00e9e de fonds et situations sp\u00e9ciales.\",\"publisher\":{\"@id\":\"https:\/\/fournel-advisory.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fournel-advisory.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fournel-advisory.com\/#organization\",\"name\":\"FOURNEL ADVISORY\",\"url\":\"https:\/\/fournel-advisory.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png\",\"contentUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png\",\"width\":2363,\"height\":1323,\"caption\":\"FOURNEL ADVISORY\"},\"image\":{\"@id\":\"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CONSEIL M&A BUY-SIDE - FOURNEL ADVISORY","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/","og_locale":"en_GB","og_type":"article","og_title":"CONSEIL M&A BUY-SIDE - FOURNEL ADVISORY","og_description":"FOURNEL ADVISORY accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition, aux c\u00f4t\u00e9s de SUBSTIPHARM, d\u2019une participation conjointe majoritaire au capital de VECTANS PHARMA. Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]","og_url":"https:\/\/fournel-advisory.com\/en\/transaction\/conseil-ma-buy-side\/","og_site_name":"FOURNEL ADVISORY","article_modified_time":"2025-07-16T08:07:00+00:00","og_image":[{"width":730,"height":729,"url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/","url":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/","name":"CONSEIL M&A BUY-SIDE - FOURNEL ADVISORY","isPartOf":{"@id":"https:\/\/fournel-advisory.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage"},"image":{"@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage"},"thumbnailUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png","datePublished":"2025-07-16T08:04:51+00:00","dateModified":"2025-07-16T08:07:00+00:00","breadcrumb":{"@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#primaryimage","url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png","contentUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/07\/ATHENA-VECTANS-FR.png","width":730,"height":729},{"@type":"BreadcrumbList","@id":"https:\/\/fournel-advisory.com\/transaction\/conseil-ma-buy-side\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fournel-advisory.com\/"},{"@type":"ListItem","position":2,"name":"Transactions","item":"https:\/\/fournel-advisory.com\/transactions\/"},{"@type":"ListItem","position":3,"name":"CONSEIL M&A BUY-SIDE"}]},{"@type":"WebSite","@id":"https:\/\/fournel-advisory.com\/#website","url":"https:\/\/fournel-advisory.com\/","name":"FOURNEL ADVISORY","description":"Une soci\u00e9t\u00e9 de conseil sp\u00e9cialis\u00e9e en fusions-acquisitions, lev\u00e9e de fonds et situations sp\u00e9ciales.","publisher":{"@id":"https:\/\/fournel-advisory.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fournel-advisory.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/fournel-advisory.com\/#organization","name":"FOURNEL ADVISORY","url":"https:\/\/fournel-advisory.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/","url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png","contentUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png","width":2363,"height":1323,"caption":"FOURNEL ADVISORY"},"image":{"@id":"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/transaction\/73314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/transaction"}],"about":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/types\/transaction"}],"author":[{"embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/media\/73315"}],"wp:attachment":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/media?parent=73314"}],"wp:term":[{"taxonomy":"type_transaction","embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/type_transaction?post=73314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}